CAR T-cell therapy gets breakthrough designationJuly 9, 2014Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Increasing AYA enrollment in cancer trialsJuly 9, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsRelated Issues
EC expands indication for ofatumumabJuly 8, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Adipose-derived SCs can resist methotrexateJuly 8, 2014Leukemia, Myelodysplasia, TransplantationPediatricsRelated Issues
Study validates drug’s efficacy in CLL/SLLJuly 3, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Phase 2 results lead to breakthrough designationJuly 2, 2014Leukemia, Myelodysplasia, TransplantationALL
Enhancing gene delivery to HSCsJune 30, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Ofatumumab falls short in CLL, DLBCLJune 29, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Group finds master regulator of MYCJune 27, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Long-term complications after ALL minimal, study showsJune 25, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Team reports new method of chemo deliveryJune 25, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingPediatricsRelated Issues
Predicting problems in families of cancer patientsJune 25, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHematology NursingRelated Issues
